Immunohisto‐cytochemical correlation of DAP IV‐CD 26 reactivity with immunblogic markers of lymphocyte activation in human lymphoid tissues
- 1 July 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (3) , 325-332
- https://doi.org/10.1111/j.1365-2141.1990.tb04344.x
Abstract
Summary. The topographic distribution of the dipeptidylami-nopeptidase IV (DAP IV-CD 26) and II (DAP II) positive T-cell population in six reactive lymph nodes and seven follicular B-cell non-Hodgkin's lymphomas (NHL) was analysed with regard to the distribution of activated T-cells, as visualized by a panel of monoclonal antibodies including Tac-CD 25, HLA-DR, OKT 9-CD 71, ICAM-1-CD 54, LFA-1-CD 11a. For comparative studies serial frozen sections of the lymph nodes were tested by enzyme histochemistry and immunohistochemistry. In addition, cell suspensions obtained from 10 B-NHL and interleukin-2 (IL-2) activated T-cells were investigated by a combined cytochemical and immunological method for simultaneous visualization of DAP IV-CD 26 cytoplasmic activity and surface immunostaining for markers of lymphocyte activation. Both in reactive and lymphomatous lymph nodes the topographic distribution of DAP IV-CD 26+ and DAP II+ lymphocytes was rather similar to that of Tac-CD 25+ lymphocytes. On the contrary, the DAP IV-CD 26 and DAP II distribution pattern substantially differed from that of the other immunologic markers. In a cell suspension of IL-2 activated T-cells, more than 80% of the cells with a blastic morphology were DAP IV-CD 26+: DAP IV-CD 26+ cells coexpressing Tac-CD 25, OKT 9-CD 71, HLA-DR positivity, relative to the total number of DAP IV-CD 26 positive cells, were 90.5%, 70.5% and 87% respectively. Only small (not activated) lymphocytes expressed a focal cytoplasmic DAP II positivity. In cell suspensions from 10 cases of B-NHL the mean percentage of DAP IV-CD 26+ Tac-CD 25+ cells was 75.8. Only a small number of DAP IV-CD 26+ cells coexpressed HLA-DR, the mean percentage being 9.6. The results support the view that DAP IV-CD 26 may be considered as a marker of lymphocyte activation; this marker seems to be restricted to T lymphocytes that reside in the T dependent areas of reactive lymph nodes and to non malignant T-cells surrounding neoplastic follicles of follicular NHL.This publication has 38 references indexed in Scilit:
- Dipeptidyl Peptidase IV in Human T LymphocytesScandinavian Journal of Immunology, 1989
- A Modified Cytochemical Method for DAP IV Demonstration which Enables Simultaneous Visualization of Cell Surface ImmunostainingActa Haematologica, 1988
- The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitroEuropean Journal of Immunology, 1986
- Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.The Journal of Experimental Medicine, 1985
- Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IVCellular Immunology, 1985
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984
- Distinct classes of human T-cell activation antigensCellular Immunology, 1984
- Enzymehistochemical staining of Tμ lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV)British Journal of Haematology, 1982
- Enzymehistochemical staining of Tμ lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV)British Journal of Haematology, 1982
- Proteinases in pathology. Usefulness of histochemical methodsJournal of Histochemistry & Cytochemistry, 1981